Precision BioSciences Inc (DTIL)
10.52
-0.32
(-2.95%)
USD |
NASDAQ |
May 03, 16:00
11.95
+1.43
(+13.59%)
After-Hours: 06:55
Precision BioSciences Accounts Receivable (Quarterly): 0.901M for Dec. 31, 2023
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.901M |
| September 30, 2023 | 3.51M |
| June 30, 2023 | 0.652M |
| March 31, 2023 | 0.694M |
| December 31, 2022 | 0.72M |
| September 30, 2022 | 0.715M |
| June 30, 2022 | 50.51M |
| March 31, 2022 | 0.488M |
| December 31, 2021 | 0.488M |
| September 30, 2021 | 0.488M |
| June 30, 2021 | 0.488M |
| Date | Value |
|---|---|
| March 31, 2021 | 19.26M |
| December 31, 2020 | 10.00M |
| September 30, 2020 | 10.12M |
| June 30, 2020 | 0.083M |
| March 31, 2020 | 3.858M |
| December 31, 2019 | 0.965M |
| September 30, 2019 | 0.25M |
| June 30, 2019 | 0.25M |
| March 31, 2019 | 6.157M |
| December 31, 2018 | 0.523M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.083M
Minimum
Jun 2020
50.51M
Maximum
Jun 2022
5.497M
Average
0.715M
Median
Sep 2022
Accounts Receivable (Quarterly) Benchmarks
| Altimmune Inc | 1.111M |
| BioVie Inc | -- |
| Adial Pharmaceuticals Inc | -- |
| Gritstone Bio Inc | -- |
| Humacyte Inc | 0.00 |